17.92

2.71% -0.50

Clearpoint Neuro Inc (CLPT)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Clearpoint Neuro Inc stock is traded at $17.92, with a volume of 251.88K. It is down -2.71% in the last 24 hours and up +15.28% over the past month. ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.

Previous Close:

$18.42

Open:

$18.5

24h Volume:

251.88K

Relative Volume:

1.04

Market Cap:

$494.32M

Revenue:

$30.43M

Net Income/Loss:

$-18.15M

P/E Ratio:

-25.97

EPS:

-0.69

Net Cash Flow:

$-9.08M

1W Performance:

+18.56%

1M Performance:

+15.28%

6M Performance:

+148.54%

1Y Performance:

+130.93%

1-Day Range:

$17.79

$18.89

1-Week Range:

$14.75

$19.00

52-Week Range:

$5.105

$19.00

Clearpoint Neuro Inc Stock (CLPT) Company Profile

Name

Clearpoint Neuro Inc

Sector

Healthcare (1175)

Industry

Medical Devices (162)

Phone

(949) 900-6833

Address

120 S. SIERRA AVENUE, SOLANA BEACH, CA

Employee

107

Twitter

@intent

Next Earnings Date

2024-11-07

Latest SEC Filings

CLPT's Discussions on Twitter

Compare CLPT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CLPT Clearpoint Neuro Inc	17.92	494.32M	30.43M	-18.15M	-9.08M	-0.69
ABT Abbott Laboratories	117.78	204.28B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	390.49	148.86B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	100.31	147.84B	15.91B	1.79B	1.89B	1.21
MDT Medtronic Plc	87.84	112.64B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	69.04	40.72B	6.60B	4.16B	490.10M	6.93

Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-25-24	Resumed	B. Riley Securities	Buy
Oct-24-23	Initiated	Stifel	Buy
Feb-16-23	Resumed	B. Riley Securities	Buy
Apr-05-22	Resumed	B. Riley Securities	Buy
Mar-18-21	Initiated	Lake Street	Buy
Jul-17-20	Initiated	B. Riley FBR	Buy

View All

Clearpoint Neuro Inc Stock (CLPT) Latest News

Jan 22, 2025

ClearPoint Neuro (CLPT) Surges 22.5%: Is This an Indication of Further Gains? - Yahoo Finance

Jan 22, 2025

Lake Street Capital Issues Positive Forecast for ClearPoint Neuro (NASDAQ:CLPT) Stock Price - Defense World

Jan 22, 2025

ClearPoint Neuro (NASDAQ:CLPT) Sets New 12-Month High After Analyst Upgrade - Defense World

Jan 22, 2025

Clearpoint Neuro stock target lifted, buy rating on robust performance By Investing.com - Investing.com Canada

Jan 22, 2025

Jan 21, 2025

ClearPoint Neuro (NASDAQ:CLPT) Sets New 12-Month High Following Analyst Upgrade - MarketBeat

Jan 21, 2025

Clearpoint Neuro stock target lifted, buy rating on robust performance - MSN

Jan 21, 2025

ClearPoint Neuro (NASDAQ:CLPT) Given New $30.00 Price Target at Lake Street Capital - MarketBeat

Jan 21, 2025

Jan 10, 2025

Barclays PLC Boosts Stock Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World

Jan 10, 2025

Jan 08, 2025

Trend Tracker for (CLPT) - Stock Traders Daily

Jan 08, 2025

Jan 07, 2025

Geode Capital Management LLC Buys 4,170 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World

Jan 07, 2025

Jan 03, 2025

Here's What Could Help ClearPoint Neuro (CLPT) Maintain Its Recent Price Strength - MSN

Jan 03, 2025

State Street Corp Has $1.18 Million Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World

Jan 03, 2025

Dec 30, 2024

Jane Street Group LLC Has $1.14 Million Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World

Dec 30, 2024

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Sold by Jane Street Group LLC - MarketBeat

Dec 30, 2024

Dec 18, 2024

Long Term Trading Analysis for (CLPT) - Stock Traders Daily

Dec 18, 2024

Dec 10, 2024

Conway Capital Management Inc. Takes Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat

Dec 10, 2024

After Leaping 26% ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Are Not Flying Under The Radar - Simply Wall St

Dec 10, 2024

Dec 09, 2024

Pekin Hardy Strauss Inc. Invests $541,000 in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat

Nov 25, 2024

Nov 24, 2024

Oppenheimer & Co. Inc. Takes Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World

Nov 24, 2024

West Pharmaceutical Services (NYSE:WST) & ClearPoint Neuro (NASDAQ:CLPT) Critical Comparison - Defense World

Nov 24, 2024

Nov 20, 2024

Global MRI Guided Neurosurgical Ablation Market Poised for Steady Growth, Projected to Reach USD 227.56 Million by 2034 Driven by Growing Adoption and Advancements in Non-Cooled Laser Systems: FMI - GlobeNewswire Inc.

Nov 20, 2024

Nov 16, 2024

(CLPT) Investment Analysis - Stock Traders Daily

Nov 16, 2024

Nov 15, 2024

ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain - AccessWire

Nov 15, 2024

Nov 14, 2024